PUBLIC-PRIVATE PARTNERSHIP AS A FACTOR IN THE DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY ECONOMY OF THE REPUBLIC OF KAZAKHSTAN

Abstract

The aim. Public-private partnership is a qualitative method of accelerating the growth rate of the country’s economy and its individual components. However, it is also important to skillfully apply the features of this method, assessing the peculiarities of the functioning of a particular country or sector. This makes it relevant to consider the specifics of public-private partnerships in the Republic of Kazakhstan and, in particular, in the pharmaceutical industry. Thus, the main purpose of the study was to assess the peculiarities of the development of the pharmaceutical industry of the Republic of Kazakhstan and the impact of public-private partnerships on it. This includes understanding the role public-private partnerships play in enhancing the efficiency and innovation of the industry. Materials and methods. This study focuses specifically on the Republic of Kazakhstan, as the public-private partnership model varies significantly across countries. The main methods used were analysis, historical method, de-duction, and modelling. The specific legislative framework, local economic conditions, and the unique challenges of Kazakhstan’s pharmaceutical sector were considered to provide relevant insights. Results. The authors showed that this area is actively developing; every year, many projects are implemented in various sectors of the economy with the help of this type of interaction. Certain results are also observed in the healthcare industry, which borders the pharmaceutical industry. However, in the context of the production of medicines or the latest technologies, there are certain problems. This industry receives insufficient investment, which is why it does not have the opportunity to develop effectively. This indicates the urgency of more decisive state intervention, including through the use of public-private partnerships. In addition, the study describes some projects that have already been implemented in Kazakhstan and shows the benefits that the state has achieved from their implementation. Conclusions. The paper brings new knowledge in the context of the investigation of public-private partnership as a method of increasing the efficiency of the functioning of the economy as a whole, and also allows for a better understanding of some features of the development of the Republic of Kazakhstan as a whole and its pharmaceutical industry in particular.